Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ENOXACIN
(1991)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Bacterial Infections
ENOXACIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
325OGW249P
Molecule Type:
Small molecule
Molecular Formula:
C15H17FN4O3
Molecular Weight:
320.32
AlogP:
0.66
PSA:
87.46
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PRAVASTATIN SODIUM
(1991)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hypothyroidism; Myocardial Infarction; Nephrotic Syndrome
PRAVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
3M8608UQ61
Molecule Type:
Small molecule
Molecular Formula:
C23H35NaO7
Molecular Weight:
446.52
AlogP:
2.44
PSA:
124.29
HBD:
4.0
HBA:
#RotB:
10.0
Source:
FOSCARNET
(1991)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
FOSCARNET
×
Maximum Phase:
4
First Approval:
1991
UNII:
364P9RVW4X
Molecule Type:
Small molecule
Molecular Formula:
CH3O5P
Molecular Weight:
126.0
AlogP:
-0.16
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
AZITHROMYCIN
(1991)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION; OPHTHALMIC; ORAL
Approved
Bacterial Infections; Bronchitis, Chronic; Conjunctivitis, Bacterial; Cystic Fibrosis; Eye Infections; Fibrosis; HIV Infections; Infections; Otitis Media; Pelvic Inflammatory Disease; Pharyngitis; Pneumonia; Pulmonary Disease, Chronic Obstructive; Sinusitis; Sprains and Strains; Tonsillitis; Ulcer; Urethritis; Uterine Cervicitis
AZITHROMYCIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
F94OW58Y8V
Molecule Type:
Small molecule
Molecular Formula:
C38H72N2O12
Molecular Weight:
749.0
AlogP:
1.9
PSA:
180.08
HBD:
5.0
HBA:
#RotB:
7.0
Source:
BENAZEPRIL
(1991)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
BENAZEPRIL
×
Maximum Phase:
4
First Approval:
1991
UNII:
UDM7Q7QWP8
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O5
Molecular Weight:
424.5
AlogP:
2.57
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TICLOPIDINE HYDROCHLORIDE
(1991)
Small molecule
Purinergic receptor P2Y12 antagonist
ORAL
Approved
Stroke; Thrombosis
TICLOPIDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
A1L4914FMF
Molecule Type:
Small molecule
Molecular Formula:
C14H15Cl2NS
Molecular Weight:
300.25
AlogP:
3.96
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
GALLIUM NITRATE
(1991)
Small molecule
Hydroxyapatite sequestering agent
INJECTION
Approved
Unknown
GALLIUM NITRATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
VRA0C6810N
Molecule Type:
Small molecule
Molecular Formula:
GaN3O9
Molecular Weight:
255.74
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FELODIPINE
(1991)
Small molecule
Mineralocorticoid receptor antagonist
ORAL
Approved
Cardiovascular Diseases; Diabetes Mellitus; Hypertension
FELODIPINE
×
Maximum Phase:
4
First Approval:
1991
UNII:
OL961R6O2C
Molecule Type:
Small molecule
Molecular Formula:
C18H19Cl2NO4
Molecular Weight:
384.26
AlogP:
3.96
PSA:
64.63
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SERTRALINE
(1991)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
SERTRALINE
×
Maximum Phase:
4
First Approval:
1991
UNII:
QUC7NX6WMB
Molecule Type:
Small molecule
Molecular Formula:
C17H17Cl2N
Molecular Weight:
306.24
AlogP:
5.18
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PENTOSTATIN
(1991)
Small molecule
Adenosine deaminase inhibitor
INJECTION
Approved
Anemia; Leukemia, Hairy Cell; Neoplasms
PENTOSTATIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
395575MZO7
Molecule Type:
Small molecule
Molecular Formula:
C11H16N4O4
Molecular Weight:
268.27
AlogP:
-1.18
PSA:
112.13
HBD:
4.0
HBA:
#RotB:
2.0
Source:
SIMVASTATIN
(1991)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Cardiovascular Diseases; Coronary Artery Disease; Coronary Disease; Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Myocardial Infarction; Stroke
SIMVASTATIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
AGG2FN16EV
Molecule Type:
Small molecule
Molecular Formula:
C25H38O5
Molecular Weight:
418.57
AlogP:
4.59
PSA:
72.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
LEVORPHANOL
(1991)
Small molecule
Unknown
Unknown
Approved
Unknown
LEVORPHANOL
×
Maximum Phase:
4
First Approval:
1991
UNII:
27618J1N2X
Molecule Type:
Small molecule
Molecular Formula:
C17H23NO
Molecular Weight:
257.38
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
0.0
Source:
PAMIDRONIC ACID
(1991)
Small molecule
Unknown
Unknown
Approved
Bone Diseases
PAMIDRONIC ACID
×
Maximum Phase:
4
First Approval:
1991
UNII:
OYY3447OMC
Molecule Type:
Small molecule
Molecular Formula:
C3H11NO7P2
Molecular Weight:
235.07
AlogP:
-1.66
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
4.0
Source:
FOSINOPRIL
(1991)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
FOSINOPRIL
×
Maximum Phase:
4
First Approval:
1991
UNII:
R43D2573WO
Molecule Type:
Small molecule
Molecular Formula:
C30H46NO7P
Molecular Weight:
563.67
AlogP:
6.12
PSA:
110.21
HBD:
1.0
HBA:
#RotB:
14.0
Source:
TICLOPIDINE
(1991)
Small molecule
Unknown
Unknown
Approved
Thrombosis
TICLOPIDINE
×
Maximum Phase:
4
First Approval:
1991
UNII:
OM90ZUW7M1
Molecule Type:
Small molecule
Molecular Formula:
C14H14ClNS
Molecular Weight:
263.79
AlogP:
3.96
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
2.0
Source:
PREDNICARBATE
(1991)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Adrenal Hyperplasia, Congenital; Anemia; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Brain Neoplasms; Bursitis; Conjunctivitis, Allergic; Dermatitis, Atopic; Endocrine System Diseases; Inflammation; Multiple Sclerosis; Neoplasms; Osteoarthritis; Peptic Ulcer; Rhinitis, Allergic; Skin Diseases; Spondylitis; Tenosynovitis; Uveitis, Posterior
PREDNICARBATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
V901LV1K7D
Molecule Type:
Small molecule
Molecular Formula:
C27H36O8
Molecular Weight:
488.58
AlogP:
3.7
PSA:
116.2
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CLARITHROMYCIN
(1991)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Bacterial Infections; Bronchitis, Chronic; Duodenal Ulcer; Infections; Maxillary Sinusitis; Otitis Media; Pharyngitis; Pneumonia; Sinusitis; Tonsillitis
CLARITHROMYCIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
H1250JIK0A
Molecule Type:
Small molecule
Molecular Formula:
C38H69NO13
Molecular Weight:
747.96
AlogP:
2.44
PSA:
182.91
HBD:
4.0
HBA:
#RotB:
8.0
Source:
RITODRINE HYDROCHLORIDE
(1991)
Small molecule
Beta-2 adrenergic receptor agonist
INJECTION; ORAL
Approved
Unknown
RITODRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
ESJ56Q60GC
Molecule Type:
Small molecule
Molecular Formula:
C17H22ClNO3
Molecular Weight:
323.82
AlogP:
2.35
PSA:
72.72
HBD:
4.0
HBA:
#RotB:
6.0
Source:
RAMIPRIL
(1991)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Cardiovascular Diseases; Coronary Artery Disease; Diabetes Mellitus; Heart Failure; Hypertension; Myocardial Infarction; Stroke
RAMIPRIL
×
Maximum Phase:
4
First Approval:
1991
UNII:
L35JN3I7SJ
Molecule Type:
Small molecule
Molecular Formula:
C23H32N2O5
Molecular Weight:
416.52
AlogP:
2.38
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LORACARBEF
(1991)
Small molecule
Bacterial penicillin-binding protein inhibitor
ORAL
Approved
Bacterial Infections
LORACARBEF
×
Maximum Phase:
4
First Approval:
1991
UNII:
3X11EVM5SU
Molecule Type:
Small molecule
Molecular Formula:
C16H16ClN3O4
Molecular Weight:
349.77
AlogP:
0.71
PSA:
112.73
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DOXACURIUM CHLORIDE
(1991)
Small molecule
Muscle-type nicotinic acetylcholine receptor antagonist
INJECTION
Approved
Unknown
DOXACURIUM CHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
M78TVM3G5Z
Molecule Type:
Small molecule
Molecular Formula:
C56H78Cl2N2O16
Molecular Weight:
1106.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PRAVASTATIN
(1991)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PRAVASTATIN
×
Maximum Phase:
4
First Approval:
1991
UNII:
KXO2KT9N0G
Molecule Type:
Small molecule
Molecular Formula:
C23H36O7
Molecular Weight:
424.53
AlogP:
2.44
PSA:
124.29
HBD:
4.0
HBA:
#RotB:
10.0
Source:
SERTRALINE HYDROCHLORIDE
(1991)
Small molecule
Serotonin transporter inhibitor
ORAL
Approved
Depressive Disorder, Major; Headache; Obsessive-Compulsive Disorder; Phobia, Social; Stress Disorders, Post-Traumatic
SERTRALINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
UTI8907Y6X
Molecule Type:
Small molecule
Molecular Formula:
C17H18Cl3N
Molecular Weight:
342.7
AlogP:
5.18
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PAMIDRONATE DISODIUM
(1991)
Small molecule
Farnesyl diphosphate synthase inhibitor
INJECTION
Approved
Unknown
PAMIDRONATE DISODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
8742T8ZQZA
Molecule Type:
Small molecule
Molecular Formula:
C3H19NNa2O12P2
Molecular Weight:
369.11
AlogP:
-1.66
PSA:
161.31
HBD:
6.0
HBA:
#RotB:
4.0
Source:
NABUMETONE
(1991)
Small molecule
Cyclooxygenase-2 inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Osteoarthritis; Rheumatic Diseases
NABUMETONE
×
Maximum Phase:
4
First Approval:
1991
UNII:
LW0TIW155Z
Molecule Type:
Small molecule
Molecular Formula:
C15H16O2
Molecular Weight:
228.29
AlogP:
3.37
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FLUDARABINE PHOSPHATE
(1991)
Small molecule
DNA polymerase (alpha/delta/epsilon) inhibitor
INJECTION; ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms
FLUDARABINE PHOSPHATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
1X9VK9O1SC
Molecule Type:
Small molecule
Molecular Formula:
C10H13FN5O7P
Molecular Weight:
365.21
AlogP:
-1.72
PSA:
186.07
HBD:
5.0
HBA:
#RotB:
4.0
Source:
FOSCARNET SODIUM
(1991)
Small molecule
Human herpesvirus 1 DNA polymerase inhibitor
INJECTION
Approved
Cytomegalovirus Retinitis; Pneumonia; Primary Immunodeficiency Diseases
FOSCARNET SODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
964YS0OOG1
Molecule Type:
Small molecule
Molecular Formula:
CNa3O5P
Molecular Weight:
191.95
AlogP:
-0.16
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
1.0
Source:
DIDANOSINE
(1991)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
DIDANOSINE
×
Maximum Phase:
4
First Approval:
1991
UNII:
K3GDH6OH08
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4O3
Molecular Weight:
236.23
AlogP:
-0.21
PSA:
93.03
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ONDANSETRON HYDROCHLORIDE
(1991)
Small molecule
Serotonin 3a (5-HT3a) receptor antagonist
INJECTION; ORAL
Approved
Nausea; Postoperative Nausea and Vomiting; Vomiting
ONDANSETRON HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
NMH84OZK2B
Molecule Type:
Small molecule
Molecular Formula:
C18H24ClN3O3
Molecular Weight:
365.86
AlogP:
3.13
PSA:
39.82
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ISOSORBIDE MONONITRATE
(1991)
Small molecule
Soluble guanylate cyclase activator
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases; Coronary Artery Disease
ISOSORBIDE MONONITRATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
LX1OH63030
Molecule Type:
Small molecule
Molecular Formula:
C6H9NO6
Molecular Weight:
191.14
AlogP:
-1.28
PSA:
91.06
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BENAZEPRIL HYDROCHLORIDE
(1991)
Small molecule
Angiotensin-converting enzyme inhibitor
Unknown
Approved
Diabetes Mellitus; Hypertension; Renal Insufficiency; Stroke
BENAZEPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
N1SN99T69T
Molecule Type:
Small molecule
Molecular Formula:
C24H29ClN2O5
Molecular Weight:
460.96
AlogP:
2.57
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LEVORPHANOL TARTRATE
(1991)
Small molecule
Mu opioid receptor agonist
INJECTION; ORAL
Approved
Unknown
LEVORPHANOL TARTRATE
×
Maximum Phase:
4
First Approval:
1991
UNII:
04WQU6T9QI
Molecule Type:
Small molecule
Molecular Formula:
C21H33NO9
Molecular Weight:
443.49
AlogP:
3.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
0.0
Source:
FOSINOPRIL SODIUM
(1991)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Heart Failure; Hypertension
FOSINOPRIL SODIUM
×
Maximum Phase:
4
First Approval:
1991
UNII:
NW2RTH6T2N
Molecule Type:
Small molecule
Molecular Formula:
C30H45NNaO7P
Molecular Weight:
585.65
AlogP:
6.12
PSA:
110.21
HBD:
1.0
HBA:
#RotB:
14.0
Source:
QUINAPRIL HYDROCHLORIDE
(1991)
Small molecule
Angiotensin-converting enzyme inhibitor
ORAL
Approved
Diabetes Mellitus; Heart Failure; Hypertension; Renal Insufficiency; Stroke
QUINAPRIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1991
UNII:
33067B3N2M
Molecule Type:
Small molecule
Molecular Formula:
C25H31ClN2O5
Molecular Weight:
474.99
AlogP:
2.57
PSA:
95.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
SUCCIMER
(1991)
Small molecule
Lead chelating agent
ORAL
Approved
Unknown
SUCCIMER
×
Maximum Phase:
4
First Approval:
1991
UNII:
DX1U2629QE
Molecule Type:
Small molecule
Molecular Formula:
C4H6O4S2
Molecular Weight:
182.22
AlogP:
-0.25
PSA:
74.6
HBD:
4.0
HBA:
#RotB:
3.0
Source:
LOMEFLOXACIN HYDROCHLORIDE
(1992)
Small molecule
Bacterial DNA gyrase inhibitor
ORAL
Approved
Unknown
LOMEFLOXACIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1992
UNII:
9VC7S3ZXXB
Molecule Type:
Small molecule
Molecular Formula:
C17H20ClF2N3O3
Molecular Weight:
387.81
AlogP:
1.8
PSA:
74.57
HBD:
2.0
HBA:
#RotB:
3.0
Source:
1
2
…
38
39
40
41
42
43
44
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA